Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Double-Blind Randomized Study of Mitomycin, 5-Fluorouracil and IMRT Combined With or Without Anti-PD-1 in Patients With Locally Advanced Anal Canal Squamous Carcinoma
Conditions
Interventions
PD-1 inhibitor
concurrent chemoradiotherapy
Locations
1
China
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Start Date
May 7, 2022
Primary Completion Date
May 31, 2025
Completion Date
December 31, 2025
Last Updated
May 16, 2022
NCT06050707
NCT05639972
NCT05838391
NCT06640283
NCT05040815
NCT05328765
Lead Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions